Effectiveness of Psilocybin on Depression: A Qualitative Study
Hisham Alshaikhli, Redhwan Ahmed Al-Naggar, Gwen Erlam
Electronic Journal of General Medicine April 27, 2021 DOI: 10.29333/ejgm/10862 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractPsilocybin, the active compound in magic mushrooms, shows promise for managing depression and anxiety. Interviews with ten people who used psilocybin while experiencing these conditions revealed enhanced sensory experiences, a feeling of being connected to the universe, stabilized mood, increased optimism and emotional control, and healthier emotional connections with others. Participants also reported a sense of calm and peace. Many described the drug as making new connections in their brain, leading to new perspectives and a calming influence. The findings suggest that even a single dose can have positive effects, and that professional guidance during administration is important for safety.
Study at a glance
| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 10 |
| Population | People currently taking psilocybin while experiencing depression and/or anxiety |
| Intervention | Psilocybin |
| Topics | Anxiety Psilocybin |
| Keywords | Clinical psychology Mood Qualitative research |
| Citations | 14 |
| Key finding | Psilocybin use was associated with enhanced sensory experiences, feelings of universal connection, mood stabilization, increased optimism, emotional control, and a sense of calm in people with depression and anxiety. |
Abstract
Introduction: Psilocybin mushroom use is well documented in spiritual and religious ceremonies globally. This drug is now the most popular in Europe and the USA. \nObjective: The objective of this study is to explore the experiences and effects of psilocybin on patients with depression and anxiety. \nMethod: A qualitative study was conducted interviewing ten participants currently taking psilocybin while experiencing depression and/or anxiety. Ethical approval was obtained from the University ethics committee. Participants were recruited via social media and groups are known to have used psilocybin for the treatment of anxiety and/or depression. Participants were informed of study aims and consent was obtained before interviews commenced. Confidentiality was maintained throughout this study. Interviews began with informing participants that psilocybin may be effective in the management of depression. Initially, information around the way treatment with psilocybin was obtained was sought. This was followed by queries around the effects of the drug in terms of experiences both during and after treatment. Finally, participants were asked to outline the positive effects of psilocybin on their lives. \nResults: The data were thematically coded using Grounded Theory as an underpinning philosophical paradigm. Emerging themes included enhancement of smell, vision, hearing, and taste sensations. Another theme emerging was the experience of being ‘connected with the universe’ while on the drug. Additionally, participants reported a stabilization of mood, an increase in optimism and emotional control, and a healthier emotional connection with others. Most also felt an increase in comfort, peace and calmness. Another theme that emerged centered on the mechanism of action of psilocybin. Participants stated that this substance seemed to ‘make new connections in their brain,’ resulting in new perspectives. Some participants felt this resulted in a calming influence on the mind and body. This aligns with research showing that psilocybin works by changing the thinking and improving information processing. \nConclusion: Psilocybin has promising effects on the patients with depression/anxiety even after a single dose. Psilocybin is safe but the administration should be guided by a health professional to yield safe and positive outcomes.